ARCHIVES

Group trials need prioritization, review, NCI official says.

This article is from The Cancer Letter archive.

Vol. 29 No. 30 | July 25, 2003

Download PDF Visit The Full Archive

Related Articles

New Compounds To Treat Gleevec-Resistant CML

January 26, 2007

Cancer Letter Editor Finalist for Loeb Award

May 16, 2003

In Brief: Online Genetics Glossary; ORI Misconduct Finding

February 5, 1999

Letter to the Editor: Gensia Official Says No “Threat” Implied In Question Study

May 26, 1995

DRCCA Board Cool On communications Network, Hears Report On Behavior Program

May 21, 1982

Funding opportunities listed.

June 4, 2004